Xencor (XNCR) Non-Current Debt (2023 - 2026)
Xencor's (XNCR) quarterly Non-Current Debt came in at $82.1 million in Q1 2026, down 19.36% year-on-year from $101.8 million in Q1 2025, and up 7.38% on a QoQ basis from $76.5 million in Q4 2025.
Xencor (XNCR) Non-Current Debt (2023 - 2026) Analysis & Trends
Xencor (XNCR) has 4 years of Non-Current Debt data on file, last reported at $82.1 million in Q1 2026.
- On a quarterly basis, Non-Current Debt fell 19.36% year-over-year to $82.1 million in Q1 2026; TTM through Mar 2026 was $82.1 million, a 19.36% decrease from a year earlier, with the FY2025 full-year figure at $76.5 million, down 33.59% from the prior year.
- Non-Current Debt for Q1 2026 stood at $82.1 million, up from $76.5 million in the prior quarter.
- Over the last five years, Non-Current Debt for XNCR reached as high as $161.8 million in Q4 2023 and fell as low as $76.5 million in Q4 2025.
- Historically, Non-Current Debt has averaged $114.0 million across 4 years, with a median of $108.5 million in 2024.
- Across the five-year window, Non-Current Debt plunged 33.59% in 2025 and fell 19.36% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $161.8 million in 2023, then retreated by 28.81% to $115.2 million in 2024, then plunged by 33.59% to $76.5 million in 2025, then grew by 7.38% to $82.1 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $82.1 million in Q1 2026, $76.5 million in Q4 2025, and $87.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 82.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.12 Mn |
| Dec 31, 2025 | 76.48 Mn |
| Sep 30, 2025 | 87.78 Mn |
| Jun 30, 2025 | 94.74 Mn |
| Mar 31, 2025 | 101.84 Mn |
| Dec 31, 2024 | 115.16 Mn |
| Sep 30, 2024 | 128.34 Mn |
| Jun 30, 2024 | 140.83 Mn |
| Mar 31, 2024 | 150.90 Mn |
| Dec 31, 2023 | 161.77 Mn |